With support from the NIH, Assistant Professor Quanyin Hu uses a two-step system to attack triple-negative breast cancer.
Drug Delivery
New Grant Fuels Pediatric Brain Cancer Treatments
With V Foundation funding, Assistant Professor Quanyin Hu aims to improve a cancer-killing hydrogel to improve outcomes for pediatric GBM patients.
Platelets as Protein Degraders
A cutting-edge platform developed by Assistant Professor Quanyin Hu uses protein-degrading platelets to suppress tumor regrowth and bolster immune response after surgery.
UW–Madison Leading New Research Collaboration Aimed at Treating Lung Scarring Diseases
University of Wisconsin–Madison scientists are poised to gain a better understanding of how to treat a progressive scarring disease of the lungs that kills an estimated 40,000 people every year in the United States.
Nano-Drugs on Bacteria Could Target Difficult-to-Treat Pancreatic Cancer
Employing bacteria to infiltrate that cancerous fortification and deliver drugs could aid treatment for pancreatic cancer, according to newly published findings from a team of University of Wisconsin–Madison researchers.
Assistant Professor Quanyin Hu Honored as Vilas Associate
A competitive Vilas Associates award recognizes Assistant Professor Quanyin Hu’s innovations in cell therapy research and fuels more development.
A Year of Discovery
In the 2020–21 Fiscal Year, School of Pharmacy researchers received six patents to improve drug delivery and discovery.
Advanced Polymeric Nanotechnology for Delivering Combination Cancer Therapies
Professor Glen Kwon receives a new grant from the National Institutes of Health for research targeting triple-negative breast cancer.
School of Pharmacy Welcomes Three Assistant Professors
New faculty members strengthen the School of Pharmacy’s research and education in pediatric pharmacy, drug delivery, and precision medicine.
School Launches New Nanotechnology Center for Drug Delivery
Professors Seungpyo Hong, Sandro Mecozzi, Lingjun Li and Glen Kwon are combining their expertise to create a new research center that will improve the efficacy of new drug leads.